Production (Stage)
Haemonetics Corporation
HAE
$66.06
-$0.10-0.15%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.64% | 10.83% | -11.84% | 88.41% | -34.81% |
| Total Depreciation and Amortization | -25.90% | -0.66% | 0.28% | 53.03% | -19.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -236.50% | -50.14% | 226.42% | -454.75% | -70.38% |
| Change in Net Operating Assets | 234.24% | -2.35% | 63.87% | -755.72% | 118.78% |
| Cash from Operations | 166.32% | -10.36% | 278.05% | -142.79% | 11,966.85% |
| Capital Expenditure | -772.94% | 85.04% | -21.37% | -47.60% | -332.36% |
| Sale of Property, Plant, and Equipment | 876.49% | 32.80% | -99.07% | 3,595.46% | 63.02% |
| Cash Acquisitions | -- | 100.00% | 98.82% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.82% | -61.12% | -1,716.08% | 93.58% | 70.24% |
| Cash from Investing | 203.85% | 25.66% | 83.21% | -966.15% | 95.15% |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -101.80% | -- | 100.00% | -825.61% | -1,714.29% |
| Issuance of Common Stock | -96.05% | 1,310.36% | -94.30% | 4,052.83% | -96.37% |
| Repurchase of Common Stock | -33,307.57% | 99.40% | -669.68% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.97% | -803,072.73% | 99.95% | -21,378.70% | -300.00% |
| Cash from Financing | -11,074.64% | 101.84% | -122.42% | 625.48% | -158.03% |
| Foreign Exchange rate Adjustments | 144.59% | -247.83% | 390.80% | 46.50% | -189.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -165.31% | 147.76% | -127.26% | 1,191.24% | 90.33% |